TXG 10x Genomics, Inc. Quarterly EPS earnings growth
Driven by its patents and status as a DNA analysis standard, 10x Genomics, Inc. (TXG) possesses exceptional pricing power. The quarterly EPS trend clearly illustrates the effectiveness of this strategy, where the value of 32.30 represents the most recent figure. A technological breakthrough in microfluidics has laid the foundation for the future of medicine, although management is currently seeking ways to accelerate equipment sales.
%20Year-over-year%20net%20earnings%20per%20share%20change%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_TXG_-_10x-Genomics-Inc._-_Year-over-year-net-earnings-per-share-change-for-the-last-twelve-months "TXG 10x Genomics: Quarterly EPS earnings growth in the range 07/04/2022 - 11/15/2026 | 👁️GURU.Markets👁️")
10x Genomics, Inc. (TXG) - metric breakdowns and financial figures
- market value and analyst target forecast:
- market capitalization data:
- balance sheet net asset value indicators:
- debt level and financial liquidity data:
Total Debt to Equity Ratio 10x Genomics, Inc.|TXG - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital 10x Genomics Inc|TXG - Company Total Debt Obligations|Debt to Book Capitalization Ratio 10x Genomics Inc|TXG - Company Long-Term Indebtedness|Company Short-Term Debts 10x Genomics|Quick Liquidity Indicator 10xgenomics.com
- earnings and valuation multiples indicators:
TXG - Net Financial Result|Future Profit 10x Genomics, Inc.|TXG - Market Price to Net Income Ratio|Projected Price to Earnings 10x Genomics|TXG - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple 10x Genomics|TXG - Operating profit before depreciation charges|Net earnings per share (EPS TTM) 10x Genomics|TXG - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months 10xgenomics.com|TXG - Earnings per share growth this year|Earnings growth forecast for next year 10x Genomics, Inc.
- revenue and sales proceeds data:
Analysis of all company metrics:10x Genomics, Inc.
This metric is calculated as the percentage deviation of current net earnings per share from the value of the same period last year. This indicator reflects the scaling rate of profitability and the overall operational efficiency of the business. For 10x Genomics, EPS growth is supported by high capacity utilization at cell analysis system manufacturing plants. Technical upgrades to the production lines minimize downtime, stabilizing the financial result. By analyzing the quarterly change in earnings per share, an investor determines the fundamental stability of the asset.
Key competitors
TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Intellia Therapeutics Inc (NTLA)|STOK (stoketherapeutics.com) - Quarterly EPS earnings growth|BLFS (BioLife Corp) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months Wave Life Sciences Ltd. (WVE)|Year-over-year earnings per share growth rate for the last twelve months MAZE|sionnatx.com - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PRME|TSHA - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months uniQure Corp|meiragtx.com (MGTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months RGNX|Year-over-year net earnings per share growth for the last 12 months SLDB|Quarterly EPS earnings growth Ocugen Inc|Year-over-year earnings per share growth for the last twelve months PacBio Corp (PACB)|Year-over-year net earnings per share change for the last twelve months Benitec Corp|Quarterly EPS earnings growth DSGN (Design Therapeutics, Inc.)|Quarterly EPS earnings growth rocketpharma.com RCKT|4DMT - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)
